US nonprofit academic medical center and research institution
US nonprofit academic medical center and research institution
Pelacarsen reduced lipoprotein(a) (Lp(a)) by 78% in a Phase III trial of more than 8,300 adults yet produced no reduction in major adverse cardiovascular events, raising questions about whether lowering …
You must be logged in to post a comment.